| Latest Gen Probe News Headlines |
| Date | Time | Source | |
| 11/16/2009 | 4:01PM | PRNUS | Gen-Probe Announces Webcast of Annual Briefing for Institutional Investors and Financial Analysts
SAN DIEGO, Nov. 16 /PRNewswire-FirstCall/ -- Gen-Probe Incorporated (NASDAQ:GPRO) announced today that the Company will webcast its annual meeting with institutional investors and financial analysts in New York on Thursday, December 3, 2009, at 9 a.m. Eastern Time (ET). The event will feature presentations on Gen-Probe's... More...>> |
| 10/30/2009 | 4:01PM | PRNUS | Gen-Probe to Webcast Two Upcoming Investor Presentations
- Oppenheimer 20th Annual Healthcare Conference on November 3 - - Lazard Capital Markets 6th Annual Healthcare Conference on November 18 -
SAN DIEGO, Oct. 30 /PRNewswire-FirstCall/ -- Gen-Probe Incorporated (NASDAQ:GPRO) announced today that the Company will present at the Oppenheimer 20th Annual Healthcare Conference... More...>> |
| 10/29/2009 | 4:01PM | PRNUS | Gen-Probe Reports Financial Results for Third Quarter 2009
-- Company Posts Non-GAAP EPS of $0.47(1), Excluding $0.03 of Transaction-Related Expenses, and GAAP EPS of $0.44 -- -- Record STD Sales and Tepnel Acquisition Help Company Establish New Quarterly Highs for Product Sales and Total Revenues -- -- Operating Activities Generate $31.9 Million of Cash in Quarter --
SAN DIEGO... More...>> |
| 09/14/2009 | 7:00AM | PRNUS | Gen-Probe to Consolidate Industrial Assets Into New, Independent Company
- Roka Bioscience to Develop Rapid, Accurate Molecular Tests for Biopharmaceutical Production Processes, Water and Food Testing, and Other Fields - - Transaction Enables Gen-Probe to Focus on Human Diagnostic Opportunities -
SAN DIEGO, Sept. 14 /PRNewswire-FirstCall/ -- Gen-Probe Incorporated (NASDAQ:GPRO) announced... More...>> |
| 08/04/2009 | 4:01PM | PRNUS | Gen-Probe Broadens Intellectual Property Portfolio Surrounding Automated Nucleic Acid Testing
SAN DIEGO, Aug. 4 /PRNewswire-FirstCall/ -- Gen-Probe Incorporated (NASDAQ:GPRO) announced today that it recently has been granted seven additional patents by the U.S. and European patent authorities that extend the Company's intellectual property estate related to automated instrument systems for nucleic acid testing... More...>> |
| 08/03/2009 | 5:35PM | PRNUS | Gen-Probe to Webcast Presentation at the Canaccord Adams 29th Annual Global Growth Conference
SAN DIEGO, Aug. 3 /PRNewswire-FirstCall/ -- Gen-Probe Incorporated (NASDAQ:GPRO) announced today that the Company will present at the Canaccord Adams 29th Annual Global Growth Conference on Tuesday, August 11, 2009 at 2:30 p.m. Eastern time (11:30 a.m. Pacific time). The presentation is scheduled to be webcast live... More...>> |
| 06/04/2009 | 5:14PM | PRNUS | Gen-Probe to Webcast Two Upcoming Investor Presentations
- William Blair & Company 29th Annual Growth Stock Conference on June 10 -
SAN DIEGO, June 4 /PRNewswire-FirstCall/ -- Gen-Probe Incorporated (NASDAQ:GPRO) announced today that the Company will present at the William Blair & Company 29th Annual Growth Stock Conference in Chicago at approximately 11:20 a.m. Central time... More...>> |
| 05/18/2009 | 4:01PM | PRNUS | Carl Hull Becomes Chief Executive Officer of Gen-Probe
- Hank Nordhoff Now Non-Executive Chairman of the Board -
SAN DIEGO, May 18 /PRNewswire-FirstCall/ -- Gen-Probe Incorporated (NASDAQ:GPRO) announced today that Carl W. Hull has formally succeeded the Company's long-time leader, Henry L. Nordhoff, as chief executive officer (CEO). Mr. Hull, formerly Gen-Probe's president... More...>> |
| 04/30/2009 | 4:01PM | PRNUS | Gen-Probe Reports Financial Results for First Quarter 2009
-- Company Posts Non-GAAP EPS of $0.51(1), Excluding $0.02 of Expenses Related to Tepnel Acquisition --
SAN DIEGO, April 30 /PRNewswire-FirstCall/ -- Gen-Probe Incorporated (NASDAQ:GPRO) today reported financial results for the first quarter of 2009, including non-GAAP earnings per share (EPS) of $0.51.
"Gen-Probe... More...>> |
| 04/29/2009 | 4:07PM | PRNUS | Gen-Probe and DiagnoCure Amend Collaboration Agreement Surrounding PCA3-Based Prostate Cancer Tests
Gen-Probe invests US$5 million in DiagnoCure
SAN DIEGO and QUEBEC CITY, April 29 /PRNewswire-FirstCall/ -- Gen-Probe Incorporated (NASDAQ:GPRO) and DiagnoCure Inc. (TSX: CUR) today announced that the companies have signed an amendment to their 2003 license agreement, establishing new FDA submission milestones and key... More...>> |
| 04/29/2009 | 4:01PM | PRNUS | Investigational Genetic Test May Help Address Common Problems in Prostate Cancer Diagnosis
- Eight Studies Presented at Leading Urology Meeting Show that Simple Urine Test for PCA3 Gene May Improve Accuracy of Prostate Cancer Detection, Reduce Unnecessary Biopsies -
SAN DIEGO, April 29 /PRNewswire-FirstCall/ -- Eight studies presented this week at the annual meeting of the American Urological Association... More...>> |
| 04/21/2009 | 10:21AM | PRNUS | BullMarket.com Updates Outlook on Medical Device and Equipment Stocks
PRINCETON, N.J., April 21 /PRNewswire/ -- BullMarket.com (http://www.bullmarket.com/), an online investment newsletter focused on long-term growth and income-generating stocks, has provided subscribers with coverage of medical device and equipment stocks, including Intuitive Surgical (NASDAQ:ISRG), Gen-Probe (NASDAQ:GPRO... More...>> |
| 04/08/2009 | 4:44AM | PRNUS | Gen-Probe Completes Acquisition of Tepnel Life Sciences
- Transaction Brings Growth Opportunities in Transplant Diagnostics, Genetic Testing and Pharmaceutical Services, Accelerates European Expansion Strategy -
SAN DIEGO, April 8 /PRNewswire-FirstCall/ -- Gen-Probe (NASDAQ:GPRO) announced today that the Company has completed its acquisition of Tepnel Life Sciences, plc... More...>> |
| 04/01/2009 | 4:01PM | PRNUS | Gen-Probe, Roche Prevail in Arbitration With Digene Concerning Human Papillomavirus Agreement
SAN DIEGO, April 1 /PRNewswire-FirstCall/ -- Gen-Probe (NASDAQ:GPRO) announced today that the Company, along with its co-respondents F. Hoffmann-La Roche Ltd. and Roche Molecular Systems, Inc., has prevailed in its arbitration with Digene (now Qiagen) concerning the Company's supply and purchase agreement with Roche... More...>> |
| 03/23/2009 | 4:01PM | PRNUS | Gen-Probe Board of Directors Elects Carl Hull Chief Executive Officer
- Hank Nordhoff, CEO Since 1994, to Serve as Non-Executive Chairman of the Board -
SAN DIEGO, March 23 /PRNewswire-FirstCall/ -- Gen-Probe Incorporated (NASDAQ:GPRO) announced today that its board of directors has elected Carl W. Hull the Company's new chief executive officer (CEO), effective May 18, 2009. He also... More...>> |
| 03/16/2009 | 9:28AM | PRNUS | Tepnel Shareholders Approve Acquisition by Gen-Probe
SAN DIEGO, March 16 /PRNewswire-FirstCall/ -- Gen-Probe Incorporated (NASDAQ:GPRO) announced that shareholders of Tepnel Life Sciences, PLC (AIM: TED) approved the acquisition of Tepnel by Gen-Probe by the requisite majorities at Court and General Meetings held in London earlier today.
More than 99% of Tepnel shareholders... More...>> |
| 03/05/2009 | 4:01PM | PRNUS | Gen-Probe to Webcast Two Upcoming Investor Presentations
- Barclays Capital Global Healthcare Conference on March 10 -
SAN DIEGO, March 5 /PRNewswire-FirstCall/ -- Gen-Probe Incorporated (NASDAQ:GPRO) announced today that the Company will present at the Barclays Capital Global Healthcare Conference in Miami on March 10, 2009 at approximately 2:30 p.m. Eastern time, and at... More...>> |
| 03/02/2009 | 4:01PM | PRNUS | Gen-Probe Borrows $170 Million Under New Line of Credit
SAN DIEGO, Calif., March 2 /PRNewswire-FirstCall/ -- Gen-Probe Incorporated (NASDAQ:GPRO) announced today that it is borrowing $170 million under a newly issued line of credit to finance its pending acquisition of Tepnel Life Sciences PLC and other general corporate activities, including its existing share repurchase... More...>> |
| 02/17/2009 | 4:01PM | PRNUS | Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2008
- Company Posts Quarterly EPS of $0.39, Total Revenues of $109.1 Million -
SAN DIEGO, Feb. 17 /PRNewswire-FirstCall/ -- Gen-Probe Incorporated (NASDAQ:GPRO) today reported strong financial results for the fourth quarter and full year ended December 31, 2008, including quarterly earnings per share (EPS) of $0.39(1... More...>> |
| 02/03/2009 | 8:00AM | PRNUS | Eric Lai Joins Gen-Probe as Senior Vice President, Research and Development
SAN DIEGO, Feb. 3 /PRNewswire-FirstCall/ -- Gen-Probe Incorporated (NASDAQ:GPRO) announced today that Eric Lai, Ph.D., has joined the Company as senior vice president, research and development.
"We are very pleased to add Eric's scientific expertise and leadership to our already strong senior management team," said... More...>> |